---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-006504"
form_type: "8-K"
ticker: "KAPA"
cik: "0001962011"
company_name: "Kairos Pharma, LTD."
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T05:15:48.022080+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Kairos Pharma replaces auditor Marcum with Weinberg; 2023 report had going concern

## Summary
- Audit committee dismissed Marcum LLP and appointed Weinberg & Company effective April 23, 2025.
- Marcum's 2023 audit report included a going concern uncertainty; 2024 report had no such modification.
- No disagreements on accounting principles or audit scope occurred during Marcum's tenure.
- Material weaknesses in internal control over financial reporting were disclosed for 2024 and 2023.
- Marcum provided a letter agreeing with the statements in this 8-K filed as Exhibit 16.1.

## SEC filing metadata
- accession: 0001641172-25-006504
- form_type: 8-K
- ticker: KAPA
- cik: 0001962011
- company_name: Kairos Pharma, LTD.
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1962011/000164117225006504/0001641172-25-006504-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1962011/000164117225006504/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-006504
- JSON: https://secwatch.observer/filing/0001641172-25-006504.json
- Plain text: https://secwatch.observer/filing/0001641172-25-006504.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.